Lieneke F.M. Ariëns

Dupilumab is very effective in a large cohort of difficult‐to‐treat adult atopic dermatitis patients: First clinical and biomarker results from the BioDay registry

Lieneke F.M. Ariëns, Jorien van der Schaft, Daphne S. Bakker et al. · Allergy · 2019 · 149 citations · Full text

Life Sciences, Dermatology, Pharmacotherapy +15

Barriers and Facilitators to eHealth Use in Daily Practice: Perspectives of Patients and Professionals in Dermatology

Lieneke F.M. Ariëns, Florine ML Schussler-Raymakers, Cynthia Frima et al. · Journal of Medical Internet Research · 2017 · 138 citations · Full text

Computing, Dermatology, Health Informatics +12

Dupilumab shows long-term effectiveness in a large cohort of treatment-refractory atopic dermatitis patients in daily practice: 52-Week results from the Dutch BioDay registry

Lieneke F.M. Ariëns, Jorien van der Schaft, Lotte S. Spekhorst et al. · Journal of the American Academy of Dermatology · 2020 · 91 citations · Full text

Life Sciences, Dermatology, Immunology +12

Economic Burden of Adult Patients with Moderate to Severe Atopic Dermatitis Indicated for Systemic Treatment

Lieneke F.M. Ariëns, Kirsten van Nimwegen, M Shams et al. · Acta Dermato Venereologica · 2019 · 75 citations · Full text

Pharmacy, Dermatology, Pharmacoeconomics +17

Dupilumab facial redness: Positive effect of itraconazole

Fleur S.A. de Beer, Daphne S. Bakker, Inge Haeck et al. · JAAD Case Reports · 2019 · 59 citations · Full text

Medicine, Dermatology, Immunology +17